£108.01

Springer Leucine-Rich Repeat Kinase 2 (LRRK2): 14 (Advances in Neurobiology, 14)

Price data last checked 14 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£108 today · previous high £108 · all-time low £108

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical
Generating forecast…
£108.01 £107.45 £107.57 £107.69 £107.82 £107.94 £108.06 21 May 2026 09 June 2026 28 June 2026 17 July 2026 05 August 2026

Price Distribution

Price distribution over 77 days • 1 price levels

Days at Price
77 days 0 19 39 58 77 £108 Days at Price

Price Analysis

Most common price: £108 (77 days, 100.0%)

Price range: £108 - £108

Price levels: 1 different prices over 77 days

Description

This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration. From the Back Cover This is the first book to assemble the leading researchers in the field of LRRK2 biology and neurology and provide a snapshot of the current state of knowledge, encompassing all major aspects of its function and dysfunction. The contributors are experts in cell biology and physiology, neurobiology, and medicinal chemistry, bringing a multidisciplinary perspective on the gene and its role in disease. The book covers the identification of LRRK2 as a major contributor to the pathogenesis of Parkinson's Disease. It also discusses the current state of the field after a decade of research, putative normal physiological roles of LRRK2, and the various pathways that have been identified in the search for the mechanism(s) of its induction of neurodegeneration.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Protein Serine/Threonine Kinases in Neurodegenerative Disorders
82% match

Protein Serine/Threonine Kinases in Neurodegenerative Disorders

Elsevier

£145.07 06 Aug 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
82% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£107.23 18 Aug 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
81% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£117.61 31 Jul 2026
Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)
81% match

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Springer

£114.71 05 Aug 2026
Parkinson's Disease: Current and Future Therapeutics and Clinical Trials
80% match

Parkinson's Disease: Current and Future Therapeutics and Clinical Trials

Cambridge University Press

£94.61 05 Aug 2026
Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)
80% match

Atypical Parkinsonian Disorders: Clinical and Research Aspects (Current Clinical Neurology)

Humana

£59.23 04 Aug 2026
Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)
80% match

Behavioral Neurobiology of Huntington's Disease and Parkinson's Disease: 22 (Current Topics in Behavioral Neurosciences, 22)

Springer

£76.38 08 Aug 2026
Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)
79% match

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Springer

£108.01 12 Aug 2026
Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive
79% match

Malattia di Parkinson e parkinsonismi: La prospettiva delle neuroscienze cognitive

Springer

£59.55 08 Aug 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
79% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£144.94 05 Aug 2026
79% match

Epigenetics and miRNA in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Elsevier

£157.99 04 Aug 2026
Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)
79% match

Nonmotor Parkinson's: The Hidden Face: The Many Hidden Faces (Volume 133) (International Review of Neurobiology, Volume 133)

Elsevier

£156.39 04 Aug 2026
RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)
79% match

RNA Metabolism in Neurodegenerative Diseases: 20 (Advances in Neurobiology, 20)

Springer

£76.38 30 Jul 2026
Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)
79% match

Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)

Springer

£113.98 07 Aug 2026
Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)
79% match

Central Functions of the Ghrelin Receptor: 25 (The Receptors, 25)

Springer

£101.58 05 Aug 2026
Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)
79% match

Pathogenesis of Neurodegenerative Disorders (Contemporary Neuroscience)

Humana

£147.14 05 Aug 2026
Neurodegenerative Disorders: A Clinical Guide
79% match

Neurodegenerative Disorders: A Clinical Guide

Springer

£60.42 05 Aug 2026
Handbook of Non-Motor Symptoms in Parkinson's Disease
79% match

Handbook of Non-Motor Symptoms in Parkinson's Disease

Springer

£39.77 06 Aug 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers
79% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers

Springer

£107.41 22 Jun 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
79% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.28 08 Aug 2026
The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers: 2
79% match

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers: 2

Springer

£111.47 04 Aug 2026
Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice
79% match

Pharmacological Foundations of Parkinson’s Disease: From Mechanisms to Clinical Practice

Academic Press

£137.99 04 Aug 2026
Systems Biology of Parkinson's Disease
78% match

Systems Biology of Parkinson's Disease

Springer

£108.01 05 Aug 2026
Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)
78% match

Stem Cell-based Therapy for Neurodegenerative Diseases: 1266 (Advances in Experimental Medicine and Biology, 1266)

Springer

£71.18 08 Aug 2026